| ADR Ontology |
| ADR Term |
Endolymphatic hydrops |
| ADR ID |
BADD_A07950 |
| ADR Hierarchy |
|
| Description |
An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO. [MeSH] |
| MedDRA Code |
10049934 |
| MeSH ID |
D018159
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Endolymphatic hydrops | Labyrinthine hydrops | Cochlear hydrops | Endolymphatic Hydrops | Hydrops, Endolymphatic |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02106 | Tadalafil | 0.000959% | | | BADD_D02346 | Venlafaxine | 0.000373% | |
| The 1th Page 1
Total 1 Pages
|
|
